Malaria Prevention in Vanuatu

Introduction to Malaria Risk

Vanuatu is located in Oceania where malaria transmission is intense with chloroquine-resistant Plasmodium falciparum present 1, 3
The Centers for Disease Control and Prevention recommends that travelers to Vanuatu take antimalarial prophylaxis due to the high risk of malaria transmission 4, 5

Mefloquine is recommended as the first-line prophylactic agent for areas with chloroquine-resistant P. falciparum such as Vanuatu 4, 5
The World Health Organization suggests a dosage of 250 mg once weekly for adults 4
The American Society of Tropical Medicine and Hygiene advises to begin taking mefloquine 1-2 weeks before travel, continue during travel, and for 4 weeks after leaving Vanuatu 4, 5

Doxycycline is an alternative option, with a recommended dosage of 100 mg daily for adults 7, 4
The Centers for Disease Control and Prevention recommends beginning doxycycline 1-2 days before travel, continuing during travel, and for 4 weeks after leaving Vanuatu 7, 4
Chloroquine plus proguanil is another alternative, with chloroquine 300 mg base weekly plus proguanil 200 mg daily 6, 8

Compliance is essential - most malaria deaths occur in travelers who do not fully comply with prophylaxis regimens 6, 8
The World Health Organization emphasizes the importance of beginning antimalarial medication before travel to establish the habit and ensure adequate blood levels 8
The Centers for Disease Control and Prevention advises to continue prophylaxis for 4 weeks after leaving Vanuatu (except for mefloquine which requires two tablets after the end of exposure) 4, 5

The American Society of Tropical Medicine and Hygiene recommends using insect repellents containing DEET on exposed skin 9, 10
Wearing clothing that covers most of the body, especially between dusk and dawn, is also advised 9, 10
Using pyrethrum-containing flying-insect spray in living and sleeping areas can provide additional protection 7, 10

Pregnant women should ideally avoid travel to malaria-endemic areas; if travel is necessary, chloroquine and proguanil have a long history of safe use during pregnancy 2
Asplenic travelers are at particular risk of severe malaria and need meticulous precautions 1, 2
Children require adjusted dosages based on weight 4
Travelers with renal impairment may need dose adjustments, particularly for proguanil 3

Discontinuing prophylaxis too early after return can increase the risk of malaria 8, 4
Relying solely on mosquito avoidance measures without chemoprophylaxis is not recommended 9, 10
Not seeking prompt medical attention for febrile illness after travel can lead to severe consequences 2